SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 7 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,050,048 | +271.0% | 198,400 | +250.5% | 0.01% | +300.0% |
Q2 2023 | $6,481,832 | -82.7% | 56,600 | -79.2% | 0.00% | -86.7% |
Q1 2023 | $37,517,326 | +104.0% | 272,200 | +91.8% | 0.02% | +66.7% |
Q4 2022 | $18,387,402 | -12.4% | 141,900 | -25.3% | 0.01% | 0.0% |
Q3 2022 | $20,992,000 | +177.3% | 189,900 | +88.0% | 0.01% | +200.0% |
Q2 2022 | $7,571,000 | – | 101,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PURA VIDA INVESTMENTS, LLC | 200,000 | $22,108,000 | 1.28% |
GROUP ONE TRADING, L.P. | 296,200 | $32,742,000 | 0.06% |
SIMPLEX TRADING, LLC | 88,100 | $9,738,000 | 0.01% |
JANE STREET GROUP, LLC | 189,900 | $20,992,000 | 0.01% |
IMC-Chicago, LLC | 33,400 | $3,692,000 | 0.01% |
JPMORGAN CHASE & CO | 58,200 | $6,433,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |